Stocks Slip as Pand...
Health Care: Drugs
Chembio Diagnostics Inc. (CEMI: NASDAQ)
$4.50 0.00 | 0.00%
05/24/13 - 10:06 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 941.28K | 6.21M | 2.51M | 309.06K |
| Operating Gains/Losses | 0.00 | 0.00 | 3.92K | 6.70K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -1.85M | 952.95K | -2.19M | -976.72K |
| (Increase) Decrease in Inventories | -187.78K | -951.12K | 206.74K | 263.13K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 514.42K | 733.56K | 149.78K | -476.86K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | -65.00K | -295.83K | 0.00 |
| (Increase) Decrease In Other Working Capital | 23.72K | -6.25K | 93.33K | 360.83K |
| Other Non-Cash Items | 346.22K | 184.35K | 185.08K | 207.92K |
| Net Cash From Continuing Operations | 761.08K | 2.27M | 1.02M | 251.93K |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 761.08K | 2.27M | 1.02M | 251.93K |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 13.75K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -872.44K | -726.68K | -182.29K | -390.74K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -872.44K | -726.68K | -182.29K | -376.99K |
| Issuance of Debt | 0.00 | 0.00 | 250.00K | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 120.39K | 287.55K | 37.61K | 4.55K |
| Repayment of Long-Term Debt | -14.58K | -899.70K | -54.05K | -23.48K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -53.55K | -54.98K | 0.00 | 0.00 |
| Net Cash From Financing Activities | 52.26K | -667.12K | 233.56K | -18.93K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -59.10K | 874.60K | 1.07M | -143.99K |
Portfolios with CEMI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
Latest CEMI Headlines from TheStreet
- Chembio Awarded $750,000 Cooperative Research Agreement 05.23.13 | 08:05 am
- Chembio Appoints Sharon Klugewicz As Chief Operating Officer 05.22.13 | 04:05 pm
- Chembio Enters International Distribution And Assembly Agreement With Labtest 05.21.13 | 08:05 am
- Chembio Sponsors 28th Annual AIDS Walk New York As Co-Chair Advocate 05.17.13 | 08:05 am
- Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor For Development Of Rapid, Point-of-Care Influenza Immunity Test 05.16.13 | 08:05 am
- Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity And Specificity In Evaluation By Mexico's Institute Of Epidemiological Diagnosis And Reference 05.14.13 | 09:05 am
- Chembio Diagnostics Reports First Quarter 2013 Financial Results 05.09.13 | 08:05 am
- Chembio Diagnostics Supports Recent USPSTF Routine Testing Recommendations 05.02.13 | 09:05 am
- Chembio To Host Conference Call To Discuss First Quarter 2013 Financial Results 04.25.13 | 08:04 am
- Chembio Commences CLIA Waiver Studies For DPP(R) HIV 1/2 Assay 04.18.13 | 08:04 am
Press Releases for CEMI
- Chembio Diagnostics, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 02.06.12 | 10:02 am
- Chembio Presenting At Biotech Conference - PR Newswire 01.09.12 | 08:01 am
- Chembio Provides Business Update - PR Newswire 01.03.12 | 08:01 am
- Chembio To Host Conference Call To Discuss 3rd Quarter 2011 Financial Results - PR Newswire 10.20.11 | 08:10 am
- Chembio Diagnostics' CFO Richard J. Larkin Among The Recipients Of "2011 CFO Of The Year" Award From Long Island Business News - PR Newswire 08.18.11 | 08:08 am
- Chembio To Host Conference Call To Discuss 2nd Quarter 2011 Financial Results - PR Newswire 07.20.11 | 08:07 am
- Chembio To Sponsor AIDS Walk New York 2011 - PR Newswire 05.11.11 | 08:05 am
- Chembio Corrects Previous Press Release - PR Newswire 04.21.11 | 05:04 pm
- Chembio Files PMA Module With FDA For DPP® HIV Test - PR Newswire 04.19.11 | 08:04 am
Partner Headlines for CEMI
- Q3: DPP Sales Up 49% Despite Revenue Miss - Analyst Blog - Zacks 11.13.12 | 06:11 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 06:08 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 03:08 pm
- Med-tech Companies to Watch in 2012 - Analyst Blog - Zacks 01.09.12 | 07:01 am
- Q1 2011 Financial Results... - Analyst Blog - Zacks 05.06.11 | 09:05 am
- Major Milestone for Chembio - Analyst Blog - Zacks 07.01.10 | 06:07 pm
- Chembio Diagnostics Inc. - Bull of the Day - Zacks 06.22.10 | 01:06 am
